Cargando…

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib

Robenacoxib is a veterinary‐approved non‐steroidal anti‐inflammatory drug (NSAID) of the coxib group. It possesses anti‐hyperalgesic, anti‐inflammatory and anti‐pyretic properties. Robenacoxib inhibits the cyclooxygenase (COX)‐2 isoform of COX selectively (in vitro IC(50) ratios COX‐1:COX‐2, 129:1 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lees, Peter, Toutain, Pierre‐Louis, Elliott, Jonathan, Giraudel, Jerome M., Pelligand, Ludovic, King, Jonathan N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541287/ https://www.ncbi.nlm.nih.gov/pubmed/35460083 http://dx.doi.org/10.1111/jvp.13052

Ejemplares similares

Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial
por: Speranza, Cindy, et al.
Publicado: (2015)

Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed‐Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats
por: Pelligand, L, et al.
Publicado: (2016)

Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs
por: Toutain, Céline E., et al.
Publicado: (2017)

Clinical safety of robenacoxib in cats with chronic musculoskeletal disease
por: King, Jonathan N., et al.
Publicado: (2021)

Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations
por: Toutain, Céline E., et al.
Publicado: (2018)

Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats
por: Heit, Mark C., et al.
Publicado: (2020)

Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and in silico Dose Fractionation for Calf Respiratory Pathogens
por: Pelligand, Ludovic, et al.
Publicado: (2019)

Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs
por: Friton, Gabriele, et al.
Publicado: (2017)

Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs
por: Friton, G., et al.
Publicado: (2017)

VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle
por: Toutain, Pierre-Louis, et al.
Publicado: (2019)

Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy
por: Kongara, Kavitha, et al.
Publicado: (2018)

Veterinary Medicine Needs New Green Antimicrobial Drugs
por: Toutain, Pierre-Louis, et al.
Publicado: (2016)

Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats
por: King, Jonathan N., et al.
Publicado: (2016)

Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney
por: Pelligand, L., et al.
Publicado: (2015)

Evaluation of Oral Robenacoxib for the Treatment of Postoperative Pain and Inflammation in Cats: Results of a Randomized Clinical Trial
por: King, Stephen, et al.
Publicado: (2012)

Quantitative Pharmacodynamic Characterization of Resistance versus Heteroresistance of Colistin in E. coli Using a Semimechanistic Modeling of Killing Curves
por: Mead, Andrew, et al.
Publicado: (2022)

Targeted dosing for susceptible heteroresistant subpopulations may improve rational dosage regimen prediction for colistin in broiler chickens
por: Mead, Andrew, et al.
Publicado: (2023)

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
por: Toutain, Pierre-Louis, et al.
Publicado: (2017)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial
por: Adrian, Derek, et al.
Publicado: (2021)

Evaluation of injectable robenacoxib for the treatment of post-operative pain in cats: results of a randomized, masked, placebo-controlled clinical trial
por: King, Stephen, et al.
Publicado: (2016)

Time-Kill Analysis of Canine Skin Pathogens: A Comparison of Pradofloxacin and Marbofloxacin
por: Azzariti, Stefano, et al.
Publicado: (2023)

The Decline and Fall of Materia Medica and the Rise of Pharmacology and Therapeutics in Veterinary Medicine
por: Lees, Peter, et al.
Publicado: (2022)

Comparison of post-operative analgesic efficacy of tolfenamic acid and robenacoxib in ovariohysterectomized cats
por: SATTASATHUCHANA, Panpicha, et al.
Publicado: (2018)

Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial
por: Gruet, Philippe, et al.
Publicado: (2013)

Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration
por: Fadel, Charbel, et al.
Publicado: (2022)

Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration
por: Kenward, Hannah, et al.
Publicado: (2014)

Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling
por: Dorey, Lucy, et al.
Publicado: (2017)

Effects of selective cyclooxygenase‐2 inhibitor robenacoxib on primary cells derived from feline injection‐site sarcoma
por: Lu, Chen‐Hui, et al.
Publicado: (2023)

Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study
por: Kenward, Hannah, et al.
Publicado: (2017)

The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis
por: Bennett, David, et al.
Publicado: (2013)

Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review
por: Mathew, Sam T., et al.
Publicado: (2011)

Clinical utility of estimation of glomerular filtration rate in dogs
por: McKenna, Myles, et al.
Publicado: (2019)

Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida
por: Dorey, Lucy, et al.
Publicado: (2017)

Influence of sevoflurane anesthesia with mechanical ventilation and fluid-therapy on distribution of subcutaneously administered robenacoxib in dogs
por: OYAMA, Norihiko, et al.
Publicado: (2018)

Population Pharmacokinetics of Intravenous Amoxicillin Combined With Clavulanic Acid in Healthy and Critically Ill Dogs
por: Vegas Cómitre, Maria D., et al.
Publicado: (2021)

Relationship between serum iohexol clearance, serum SDMA concentration, and serum creatinine concentration in non‐azotemic dogs
por: McKenna, Myles, et al.
Publicado: (2019)

Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs
por: Pelligand, Ludovic, et al.
Publicado: (2020)

Comparison of veterinary drugs and veterinary homeopathy: part 1
por: Lees, P., et al.
Publicado: (2017)

Comparison of veterinary drugs and veterinary homeopathy: part 2
por: Lees, P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b5qvccia7n4hqsn4tv602iqn58